Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

MicroRNAs01:22

MicroRNAs

22.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.9K
MicroRNAs01:22

MicroRNAs

3.4K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.4K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

9.3K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.3K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.1K
3.1K
RNA Interference01:23

RNA Interference

27.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.0K
Types of RNA01:20

Types of RNA

8.1K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
8.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ill Fate of Rectal Mucinous Adenocarcinoma: A Defect in Immunosurveillance or a Mucin Coating Effect?-The IMMUNOREACT 20 Study.

Cancers·2026
Same author

Preclinical Drug-Response Profiling Identifies BMI1 Inhibition as a Therapeutic Option for Hepatoblastoma.

International journal of molecular sciences·2026
Same author

ALA-PDT induces apoptosis in HPV-transformed cells through mtDNA release-mediated activation of the cGAS-STING pathway.

Photodiagnosis and photodynamic therapy·2026
Same author

Clinical Evaluation of Deep Learning-Reconstructed Postcontrast 3D T1-Weighted Volume Interpolated Breath-Hold Examination (VIBE) Compared with Standard VIBE for Detection of Internal Auditory Canal Lesions.

AJNR. American journal of neuroradiology·2026
Same author

Unveiling the molecular profile of adenosquamous gallbladder carcinoma: characterization of a Caucasian cohort.

Histopathology·2026
Same author

Proteasome Targeting with Carfilzomib Induces Reactive Oxygen Species-Mediated Apoptosis in Hepatoblastoma.

Cells·2026
Same journal

Sub1 contributes to heart failure with preserved ejection fraction driven by aging in mice.

Nature communications·2026
Same journal

The BRCA1-A complex restricts replication fork reversal-dependent DNA repair in ATM deficient cells.

Nature communications·2026
Same journal

Signaling downstream of tumor-stroma interaction regulates mucinous colorectal adenocarcinoma apicobasal polarity.

Nature communications·2026
Same journal

Click-polymerized polyenamine membranes for efficient lithium extraction.

Nature communications·2026
Same journal

Joint trajectories of brain atrophy, white matter hyperintensities and cognition quantify brain maintenance.

Nature communications·2026
Same journal

Proton shuttling at electrochemical interfaces under alkaline hydrogen evolution.

Nature communications·2026
See all related articles

Related Experiment Video

Updated: Nov 10, 2025

A Reporter Assay to Analyze Intronic microRNA Maturation in Mammalian Cells
06:48

A Reporter Assay to Analyze Intronic microRNA Maturation in Mammalian Cells

Published on: June 16, 2022

2.2K

A KRAS-responsive long non-coding RNA controls microRNA processing.

Lei Shi1,2, Peter Magee1,2, Matteo Fassan3

  • 1Transcriptional Networks in Lung Cancer Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.

Nature Communications
|April 2, 2021
PubMed
Summary
This summary is machine-generated.

Wild-type KRAS (KRASWT) amplification drives lung cancer. Researchers found KIMAT1, a KRAS-responsive lncRNA, promotes tumorigenesis by regulating microRNAs, offering a potential therapeutic target.

More Related Videos

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

2.6K
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

831

Related Experiment Videos

Last Updated: Nov 10, 2025

A Reporter Assay to Analyze Intronic microRNA Maturation in Mammalian Cells
06:48

A Reporter Assay to Analyze Intronic microRNA Maturation in Mammalian Cells

Published on: June 16, 2022

2.2K
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

2.6K
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

831

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Wild-type KRAS (KRASWT) amplification is linked to poor survival in cancer.
  • The role of KRASWT overexpression in lung cancer progression remains unclear.

Purpose of the Study:

  • To identify and characterize a KRAS-responsive long non-coding RNA (lncRNA) in lung cancer.
  • To elucidate the mechanism by which this lncRNA influences lung tumorigenesis.

Main Methods:

  • Correlation analysis of KIMAT1 and KRAS levels in cell lines and patient specimens.
  • Investigated KIMAT1's role in microRNA processing and biogenesis.
  • Assessed the impact of KIMAT1 knockdown on KRAS signaling and tumor growth in vitro and in vivo.

Main Results:

  • Identified KIMAT1 (ENSG00000228709) as a KRAS-responsive lncRNA correlating with KRAS levels.
  • KIMAT1, a MYC target, stabilizes DHX9 and NPM1 to promote oncogenic miRNA processing.
  • KIMAT1 silences p21, halting tumor suppressor miRNA biogenesis, and KRAS downstream signaling.

Conclusions:

  • KIMAT1 sustains KRAS signaling through a positive feedback loop in lung cancer progression.
  • KIMAT1 knockdown inhibits KRAS expression and downstream signaling, arresting tumor growth.
  • Targeting KIMAT1 presents a potential strategy to combat KRAS-driven lung tumorigenesis.